Tonix Pharmaceuticals, a clinical-stage biopharmac company based in Chatham, New Jersey has purchased a 44-acre site in Hamilton, Montana to build a vaccine development and commercial-scale manufacturing facility. The project comes on the heels of Tonix’s purchase of a 40,000-square-foot facility in Massachusetts to house its Advanced Development Center for development and manufacture of vaccines. Both sites are expected to support development and production of Tonix’s vaccine candidates, including potential products for horsepox, COVID-19, smallpox, monkeypox and more. Tonix expects to break ground on the Montana site later this year.
Learn More